Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has appointed M/s Karthik L & Associates, Chartered Accountants (FRN: 024924S), as the Internal Auditor of the company for Financial Year 2025-2026. The appointment was made at a board meeting held on 2nd September 2025 to comply with the requirements of the Companies Act, 2013 and SEBI listing regulations. Karthik L, the lead auditor, is a Chartered Accountant with over 5 years of experience in auditing, taxation, and company law, and has worked across industries including aviation, engineering, real estate, and construction. The signing authority is Managing Director Nanjappan Aravind (DIN: 01895602).
This is a routine regulatory compliance appointment with no direct material impact on shareholders or the stock price. It reinforces the company's internal audit and governance framework for the current financial year.